Methods: This was a prospective, single-centre collection of data regarding epidemiological,
demographic, clinical and laboratory parameters, management and outcome of COVID-19 …

Background The epidemiology of the Coronavirus-disease associated mucormycosis (CAM)
syndemic is poorly elucidated. We aimed to identify risk factors that may explain the burden …

India imposed one of the world’s strictest population-wide lockdowns on March 25, 2020 for
COVID-19. We estimated epidemiological parameters, evaluated the effect of control …

Background Enlargement of adipocyte is associated with their dysfunction and alterations in
metabolic functions. Objectives We evaluated the association of adipocyte size of …

This study endeavours to comprehensively the study the spectrum of ENT manifestations in
mild and asymptomatic COVID-19 and observe the natural course of anosmia and dysgeusia …

Introduction Ivermectin is an antiparasitic drug which has in-vitro efficacy in reducing severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) viral load. Hence, Ivermectin is …

Background: The diagnosis of CPA relies on the detection of the IgG Aspergillus antibody,
which is not freely available, especially in resource-poor settings. Point-of-care tests like …

Background: The “second wave” of the COVID-19 pandemic hit India from early April 2021
to June 2021. We describe the clinical features, treatment trends, and baseline laboratory …

Background: Hypoxia in patients with COVID-19 is one of the strongest predictors of
mortality. Silent hypoxia is characterised by the presence of hypoxia without dyspnoea. Silent …

Background: -The sharp uptick in the cases of mucormycosis in the background of the COVID19
pandemic is a cause of concern and the reasons and it’s impact remains to be seen. We …